The global airlift bioreactor market is on a trajectory of significant expansion, with estimations from Future Market Insights projecting a valuation of USD 2.4 billion in 2023, soaring to an impressive USD 6.9 billion by 2033. This growth is expected to be fueled by a compound annual growth rate (CAGR) of 11.2% during the forecast period.
Several key factors are driving this surge in demand for airlift bioreactors, including heightened research and development activities in the biotechnology sector, the rapid expansion of the biopharmaceutical industry, and the increasing number of clinical and preclinical trials being conducted worldwide. Additionally, the escalating need for single-use bioreactors is contributing to the market’s growth momentum.
Get your Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-13801
North America is anticipated to dominate the airlift bioreactor market throughout the forecast period, owing to its robust biotechnology and pharmaceutical industries. The region’s increased adoption of airlift bioreactors for the production of biological products, antibodies, and vaccines is poised to further amplify market sales.
“The airlift bioreactor market is experiencing a significant upswing, driven by the burgeoning demand from key sectors such as biotechnology and pharmaceuticals,” commented FMI. “As innovations in single-use bioreactors continue to evolve, we anticipate a sustained growth trajectory in the coming years.”
The soaring market potential of airlift bioreactors underscores their pivotal role in advancing bioprocessing capabilities and meeting the escalating demands of a rapidly evolving biotechnology landscape. With a focus on innovation and collaboration, industry stakeholders are poised to capitalize on emerging opportunities and drive the sector’s unprecedented growth.
Several factors driving the demand for airlift bioreactors:
- Rising demand for biopharmaceuticals: Monoclonal antibodies, vaccines, and other biological drugs are in high demand for treating various diseases, including cancers and viral infections. Airlift bioreactors play a crucial role in their production.
- Increased focus on vaccine development: The COVID-19 pandemic highlighted the importance of rapid vaccine development. Airlift bioreactors offer efficient production capabilities, fueling their demand in the biopharmaceutical industry.
- Growth in drug discovery and biologics preference: The rise of biologics, drugs derived from living organisms, necessitates advanced bioreactors like airlift systems. This trend is expected to continue with increasing drug discovery efforts.
- Prevalence of chronic diseases: The growing burden of chronic illnesses like cancer and diabetes creates a demand for effective treatments. Airlift bioreactors can be instrumental in producing these therapies.
Get Customization on This Report: https://www.futuremarketinsights.com/customization-available/rep-gb-13801
Some of the leading manufacturers and suppliers of airlift bioreactors are:
- Sartorius AG
- Lonza
- Shree Biocare
- Knik Technology
- Electrolab Biotech
- Rotech Inc.
- Cellexus
- Solida Biotech GmBH
- Zeta GmbH
- Kuhner shaker
Key segments:
By Product:
- Internal airlift loop bioreactor
- External airlift loop bioreactor
By Capacity:
- 5L
- 7L
- 10L
- 30L
By Material:
- Stainless steel
- Glass
By Usage:
- Single-use / disposal
- Reusable
By Production Scale:
- Laboratory scale
- Pilot-scale
- Large scale
By End-User:
- Biopharmaceutical companies
- Contract research organizations (CROs)/ Contract development and manufacturing organizations (CDMOs)
- Research and development companies
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
Get Complete Full Report: https://www.futuremarketinsights.com/checkout/13801
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube